Research
Expand New Horizons

1
SEVEN Study
SEVEN Study
Publications
SEVEN Study – 2020
BMJ Open
Post hoc study to investigate the potential causes of poor quality of cardiovascular medicines collected in sub-Saharan countries.
Secretan PH, Antignac M, Yagoubi N, Bernard M, Perier MC, Takombe JL, Balde D, N’Guetta R, Ikama MS, Zabsonre P, Aly AS.
SEVEN Study
Communications
SEVEN Study – 2016
European Society Clinical Pharmacy (ESCP) 45th Symposium on Clinical Pharmacy, Oslo
Cardiovascular drugs poor quality and mortality in 10 sub-saharan countries: The SEVEN study.
Marie Antignac, Diane MACQUART de Terline , Bara Ibrahima DIOP, Melisande Bernard, Bernard DO, Méo Stéphane IKAMA, Roland N’GUETTA, Dadhi M BALDE , Yessoufou TCHABI, Abdallahi SIDI ALY, Patrick ZABSONRE, Kumar Narayanan
SEVEN Study – 2016
World Congress of Cardiology and Cardiovascular health (WCC), Mexico
Quality of assessment of 7 cardiovascular drugs in Sub-Saharan African countries: results of the SEVEN study by drug and version of drug
Marie ANTIGNAC, Bara I. DIOP, Diane MACQUART DE TERLINE, Bernard DO, Méo S. IKAMA, Roland N’GUETTA, Dadhi M. BALDE7, Yessoufou TCHABI, Abdallahi SIDI ALY, Ibrahim ALI TOURE , Patrick ZABSONRE, Jean Marie F. DAMOROU, Jean Luc TAKOMBE, Eloi MARIJON, Xavier JOUVEN
SEVEN Study – 2015
European Society of Cardiology (ESC) Congress, London – United Kingdom
First quality assessment of cardiovascular drugs in 10 sub-Saharan African countries: the SEVEN Study
Marie Antignac, Ibrahima Bara DIOP, Bernard Do, Méo Stéphane IKAMA, Roland N’Guetta, Dadhi M BALDE, Yessoufou TCHABI, Abdallahi SIDI ALY, Eloi Marijon, Xavier Jouven.
SEVEN Study – 2015
European Society of Cardiology (ESC) Congress, London – United Kingdom
Quality of cardiovascular drugs in street markets and pharmacies in 10 sub-Saharan African countries: the SEVEN study
Antignac M., IB. Diop, M. Bernard, D. de Terline, JL. Takombe, I.Toure, P. Zabsonre, JMF. Damorou, M. Mirabel, X. Jouven.
Other studies
2
EIGHT
study

3
FEBRUARY Study

4
CADRE Study

5
COVID-19

6
AGRAF, DIABDAF…
